INTS vs STZ · $7.7M cap vs P/E 14, rev $2.16B
Intensity Therapeutics, Inc. Common stock (INTS) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported STZ revenue for 2025-02-28 was $2.16B. Net income was -$375.3M. Revenue was up 1.2% from 2024-02-29 to 2025-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
INTS currently screens at market cap $7.7M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the INTS and STZ stock pages for the full models.
Not investment advice.